|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/53 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/0031 | (2013.01) | ||
| A61K 9/0043 | (2013.01) | ||
| A61K 9/02 | (2006.01) | ||
| A61K 9/06 | (2006.01) | ||
| A61K 9/0073 | (2013.01) | ||
| A61K 9/02 | (2013.01) | ||
| A61K 9/12 | (2006.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/06 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 9/12 | (2013.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 9/2004 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/28 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/48 | (2013.01) | ||
| A61K 9/7023 | (2013.01) | ||
| A61K 31/53 | (2013.01) | ||
| A61K 9/0053 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3493809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17752530.0 |
| Date of filing the European patent application | 2017-08-02 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/045055 |
| Date | 2017-08-02 |
| (87) | Number | WO 2018/026894 |
| Date | 2018-02-08 |
| (30) | Number | Date | Country code |
| 201662370673 P | 2016-08-03 | US | |
| 201662429649 P | 2016-12-02 | US |
| (72) |
AMATANGELO, Michael , US
HU, Xiaolan , US
THAKURTA, Anjan , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | ENASIDENIB FOR TREATMENT OF MYELODYSPLASTIC SYNDROME |
| ENASIDENIB FOR TREATMENT OF MYELODYSPLASTIC SYNDROME |